Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The tumor suppressor p53 exerts its anti-neoplastic activity primarily through the induction of apoptosis. We found that cytosolic localization of endogenous wild-type or trans-activation-deficient p53 was necessary and sufficient for apoptosis. p53 directly activated the proapoptotic Bcl-2 protein Bax in the absence of other proteins to permeabilize mitochondria and engage the apoptotic program. p53 also released both proapoptotic multidomain proteins and BH3-only proteins [Proapoptotic Bcl-2 family proteins that share only the third Bcl-2 homology domain (BH3)] that were sequestered by Bcl-xL. The transcription-independent activation of Bax by p53 occurred with similar kinetics and concentrations to those produced by activated Bid. We propose that when p53 accumulates in the cytosol, it can function analogously to the BH3-only subset of proapoptotic Bcl-2 proteins to activate Bax and trigger apoptosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This includes pro-apoptotic members of the Bcl-2 family (e.g., PUMA, Bax), which mediate mitochondrial outer membrane permeabilization and subsequent caspase activation, to dismantle the cell (Nakano and Vousden, 2001; Chipuk et al., 2004; Aubrey et al., 2018).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Chipuk et al., 2004
In the citing paper
“p53 directly activates the pro-apoptotic protein Bak or disrupts the Mcl-1 and Bak complex, releasing Bak and initiating apoptosis.37,72”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [37]
In the citing paper
“Stabilized p53 forms tetramers in the nucleus, binds to target DNA and regulates gene transcription, leading to alterations in downstream signaling pathways.33–37”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [37]
Citations
Cites
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714
Self-citationTumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death
Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson, C. B., & Korsmeyer, S. J. (1995) · Cell · doi:10.1016/0092-8674(95)90411-5 · Cited by 2,100
p53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,777
Cheng, E. H.-Y. A., Wei, M. C., Weiler, S., Flavell, R. A., Mak, T. W., Lindsten, T., & Korsmeyer, S. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00320-3 · Cited by 1,707
Letai, A., Bassik, M. C., Walensky, L. D., Sorcinelli, M. D., Weiler, S., & Korsmeyer, S. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00127-7 · Cited by 1,677
Bid, Bax, and Lipids Cooperate to Form Supramolecular Openings in the Outer Mitochondrial Membrane
Kuwana, T., Mackey, M. R., Perkins, G., Ellisman, M. H., Latterich, M., Schneiter, R., Green, D. R., & Newmeyer, D. D. (2002) · Cell · doi:10.1016/s0092-8674(02)01036-x · Cited by 1,478
Self-citationp53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa
Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M., & Strasser, A. (2003) · Science · doi:10.1126/science.1090072 · Cited by 1,327
Research works printed but not linked: 1
- C. A. Vater, L. M. Bartle, C. A. Dionne, T. D. Littlewood, V. S. Goldmacher, Oncogene13, 739 (1996).
Cited by
Items 301–400 of 2,058
Reyes‐Zurita, F. J., Pachón-Peña, G., Lizárraga, D., Rufino‐Palomares, E. E., Cascante, M., & Lupiáñez, J. A. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-154 · Cited by 128
“An accumulation of p53 in the cytosol can act in a similar way to BH3-only proteins, thus inducing the oligomerization of Bax [32].”
BackgroundInfluentialReview of Chromium (VI) Apoptosis, Cell-Cycle-Arrest, and Carcinogenesis
Chiu, A. O. S., Shi, X., LEE, W. K. P., Hill, R., Wakeman, T. P., Katz, A. J., Xu, B., Dalal, N. S., Robertson, J. D., Chen, C., et al. (2010) · Journal of Environmental Science and Health Part C · doi:10.1080/10590501.2010.504980 · Cited by 131
Ischemia/reperfusion injury at the intersection with cell death
Logue, S. E., Gustafsson, Å. B., Samali, A., & Gottlieb, R. A. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.11.009 · Cited by 124
The Calcium-binding Protein S100B Down-regulates p53 and Apoptosis in Malignant Melanoma
Lin, J., Yang, Q., Wilder, P. T., Carrier, F., & Weber, D. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.155382 · Cited by 120
Kohn, K. W., & Pommier, Y. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.186 · Cited by 135
Nijboer, C. H. A., Heijnen, C. J., Groenendaal, F., May, M. J., van Bel, F., & Kavelaars, A. (2008) · Stroke · doi:10.1161/strokeaha.107.504175 · Cited by 130
Cytoplasmic p53: Bax and Forward
Chipuk, J. E., & Green, D. R. (2004) · Cell Cycle · doi:10.4161/cc.3.4.821 · Cited by 118
Self-citationWang, F., Marshall, C. B., Yamamoto, K., Li, G., Plevin, M. J., You, H., Mak, T. W., & Ikura, M. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.025 · Cited by 124
The p53 family in nervous system development and disease
Jacobs, W. B., Kaplan, D. R., & Miller, F. D. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03980.x · Cited by 133
“Finally, increased p53 promoter activity was noted in the presence of mHtt, and downstream targets of p53, such as Bax and PUMA, were up-regulated in cells expressing mHtt (Bae et al. 2005).”
BackgroundInfluentialBCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells
Ranuncolo, S. M., Polo, J. M., & Melnick, A. (2008) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2008.02.003 · Cited by 116
“P53 regulates numerous genes involved in regulation of cell survival and proliferation such as BAX and CDKN1A respectively[8,9].”
BackgroundMulti-tasking: nuclear transcription factors with novel roles in the mitochondria
Szczepanek, K., Lesnefsky, E. J., & Larner, A. C. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.05.001 · Cited by 114
Structural insight into the molecular mechanism of p53-mediated mitochondrial apoptosis
Wei, H., Qu, L., Dai, S., Li, Y., Wang, H., Feng, Y., Chen, X., Jiang, L., Guo, M., Li, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22655-6 · Cited by 114
HIV-1 Vpr-Induced Apoptosis Is Cell Cycle Dependent and Requires Bax but Not ANT
Andersen, J. L., DeHart, J. L., Zimmerman, E. S., Ardon, O., Kim, B., Jacquot, G., Benichou, S., & Planelles, V. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020127 · Cited by 115
“In other instances of DNA damage, activated p53 was shown to directly promote Bax activation [62,63].”
Backgroundp53 downstream target genes and tumor suppression: a classical view in evolution
Rozan, L. M., & El‐Deiry, W. S. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402058 · Cited by 126
Eßmann, F., Engels, I. H., Totzke, G., Schulze‐Osthoff, K., & Jänicke, R. U. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1082 · Cited by 129
“Although transcriptionally independent activities of p53 are much less understood than its function as a transcription factor (13), recent evidence suggests that cytoplasmic or mitochondrial p53 may directly interact with proapoptotic and antiapoptotic members of the Bcl-2 family, respectively, thereby inducing apopto…”
BackgroundBoregowda, S. V., Krishnappa, V., Chambers, J. W., Lograsso, P. V., Lai, W., Ortiz, L. A., & Phinney, D. G. (2012) · STEM CELLS · doi:10.1002/stem.1069 · Cited by 114
14‐3‐3γ binds to MDMX that is phosphorylated by UV‐activated Chk1, resulting in p53 activation
Jin, Y., Dai, M., Lu, S. Z., Xu, Y., Luo, Z., Zhao, Y., & Lu, H. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601010 · Cited by 131
“Also, p53 directly travels to the mitochondria, triggering apoptosis (Mihara et al, 2003; Chipuk et al, 2004; Leu et al, 2004).”
BackgroundDeath squads enlisted by the tumour suppressor p53
Michalak, E., Villunger, A., Erlacher, M., & Strasser, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.183 · Cited by 94
“There is also emerging evidence that the p53 protein may bind directly to the BAX protein and thereby induce apoptosis through a transcription-independent mechanism [101].”
Schmitt, E., Paquet, C., Beauchemin, M., & Bertrand, R. (2007) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2007.b0377 · Cited by 150
Huang, K., zhang, G. D., Huang, Y., & Diao, Y. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.12.004 · Cited by 117
p53 and its downstream proteins as molecular targets of cancer
Sun, Y. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20231 · Cited by 112
“These genes can be further subgrouped into apoptosisinducing genes such as BAX, p53-upregulated modulator of apoptosis (PUMA), or NOXA (see Figure 1) or apoptosis-inhibiting genes, such as heparinbinding EGF-like growth factor [17], Cox-2 [18], or discoidin domain receptor 1 [19].”
BackgroundGlucose Metabolism Attenuates p53 and Puma-dependent Cell Death upon Growth Factor Deprivation
Zhao, Y., Coloff, J. L., Ferguson, E. C., Jacobs, S. R., Cui, K., & Rathmell, J. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803580200 · Cited by 112
Chung, L., & Ng, Y.-C. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.08.003 · Cited by 112
“The tumor suppressor p53 can be turned on by oxidative stress as well as by DNA damage, which in turn affects apoptosis by either increasing the expression of Bax or decreasing the expression of Bcl-2 [17,46], also by directly translocating to the mitochondria to activate the apoptotic process [21,22].”
BackgroundInhibition of Bak Activation by VDAC2 Is Dependent on the Bak Transmembrane Anchor
Lazarou, M., Stojanovski, D., Frazier, A. E., Kotevski, A., Dewson, G., Craigen, W. J., Kluck, R. M., Vaux, D. L., & Ryan, M. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.159301 · Cited by 111
p53 and autophagy in cancer: Guardian of the genome meets guardian of the proteome
Ryan, K. M. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.10.020 · Cited by 129
Stress-induced p53 runs a transcription-independent death program
Erster, S. H., & Moll, U. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.187 · Cited by 127
Zhou, H.-R., Islam, Z., & Pestka, J. J. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi234 · Cited by 120
“In contrast, Chipuk et al. (2004) reported that a transcriptionindependent mechanism whereby p53 functions analogously to the BH3-only proapoptotic Bcl-2 proteins in the activation of Bax and triggering of apoptosis.”
BackgroundMitochondrial regulation of apoptotic cell death
Gogvadze, V. G., & Orrenius, S. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.04.010 · Cited by 140
Ferrante, E., Pellegrini, C., Bondioni, S., et al. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01191 · Cited by 109
“In this respect, it has been proposed that cytosolic accumulation of p53 may activate Bax and trigger mitochondrial membrane permeabilization and apoptosis by a transcription-independent mechanism (Chipuk et al. 2004).”
BackgroundMitochondrial Ribosomal Protein L41 Suppresses Cell Growth in Association with p53 and p27Kip1
Yoo, Y. A., Kim, M. J., Park, J. K., Chung, Y. M., Lee, J. H., Chi, S.-G., Kim, J. S., & Yoo, Y. D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6603-6616.2005 · Cited by 117
“the mitochondria after damage, resulting in transcription-independent apoptosis (2, 5, 13, 15, 16, 19).”
BackgroundApoptotic Pathways and Therapy Resistance in Human Malignancies
Viktorsson, K., Lewensohn, R., & Zhivotovsky, B. (2005) · Advances in cancer research · doi:10.1016/s0065-230x(05)94004-9 · Cited by 126
Coffin, A. B., Rubel, E. W., & Raible, D. W. (2013) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-013-0404-1 · Cited by 119
Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity
Wei, H., Wang, H., Wang, G., Qu, L., Jiang, L., Dai, S., Chen, X., Zhang, Y., Chen, Z., Li, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40087-2 · Cited by 132
“9 – 10).”
InfluentialEffects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy
Nambiar, D. K., Rajamani, P., & Singh, R. P. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.07.005 · Cited by 122
Cui, D., Wang, L., Jiang, W., Qi, A., Zhou, Q., & Zhang, X. L. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.054 · Cited by 114
Fibrate prevents cisplatin-induced proximal tubule cell death.
Nagothu, K. K., Bhatt, R., Kaushal, G., & Portilla, D. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00739.x · Cited by 111
“Our present study did not address the role of p53 in cisplatininduced proximal tubular cell death; however, the early effects of cisplatin injury suggest that Bax translocation could occur independently of p53 increased transcriptional activity as recently demonstrated by other investigators [27].”
ResultCell death decision by p53 via control of the mitochondrial membrane
Dashzeveg, N. K., & Yoshida, K. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.019 · Cited by 114
“For example, the binding of p53 to Bax induces MOMP in in-vitro MOMP assays in the absence of other proteins, and this function requires the proline-rich domain of p53 [11].”
BackgroundInfluentialApoptosis: molecular mechanisms and pathogenicity
Rastogi, R. P., R., & Sinha, R. P. (2010) · Technische Universität Dortmund · doi:10.17877/de290r-8930 · Cited by 106
“, 2004; Yu, 2006) is directly linked to the intrinsic or mitochondrial apoptotic pathway (Chipuk et al., 2004; Leu et al., 2004), where it interacts with anti-apoptotic Bcl-2 family proteins (Bcl-2, Bcl-XL) and stop their action to promote the activities of BH3-only proteins (Bak/Bax).”
Li, S., Jiang, Y., Sun, Q., Coffin, S., Chen, L., Qiao, K., Gui, W., & Zhu, G. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.125129 · Cited by 115
Bitomsky, N., & Hofmann, T. G. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07331.x · Cited by 125
Movassagh, M., & Foo, R. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9070-x · Cited by 120
“In addition, p53 appears to trigger MOMP and apoptosis independent of transcription through direct activation of Bax [43, 44] or Bak [45], or through binding to Bcl-2 and Bcl-xL [46].”
BackgroundChemosensitization by Knockdown of Adenine Nucleotide Translocase-2
Le Bras, M., Borgne-Sanchez, A., Touat, Z., El Dein, O. S., Deniaud, A., Maillier, E., Lecellier, G., Rebouillat, D., Lemaire, C., Kroemer, G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4407 · Cited by 106
Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis
Wu, W. K. K., Wang, X., Cheng, A. S. L., Luo, M. X. M., Ng, S. S. M., To, K. F., Chan, F. K. L., Cho, C. H., Sung, J. J. �., & Yu, J. Q. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.11.009 · Cited by 115
“[319] Chipuk JE, Kuwana T, Bouchier-Hayes L, et al.”
Focal Adhesion Kinase and p53 Signaling in Cancer Cells
Golubovskaya, V., & Cance, W. G. (2007) · International review of cytology · doi:10.1016/s0074-7696(07)63003-4 · Cited by 118
Ribosomal protein S27L is a direct p53 target that regulates apoptosis
He, H., & Sun, Y. (2006) · Oncogene · doi:10.1038/sj.onc.1210073 · Cited by 108
“Activating genes include those involved in two major apoptotic pathways: the mitochondrial pathway, such as BAX, NOXA, PUMA, p53AIP, PIGs and APAF-1, and the death receptor pathway, such as KILLER/DR5, FAS, PIDD. p53 repressed cell survival genes include IGFR, BCL-2 or survivin (Levine, 1997; Vogelstein et al., 2000;…”
BackgroundMurase, D., Hachiya, A., Amano, Y., Ohuchi, A., Kitahara, T., & Takema, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805570200 · Cited by 104
Mitochondrial translocation of Nur77 mediates cardiomyocyte apoptosis
Cheng, Z., Völkers, M., Din, S., Avitabile, D., Khan, M., Gude, N. A., Mohsin, S., Tao, B., Truffa, S., Alvarez, R., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq496 · Cited by 107
He, N., Shi, X., Zhao, Y., Tian, L., Wang, D., & Yang, X. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf3036929 · Cited by 107
Intihar, T. A., Martinez, E. A., & Gomez-Pastor, R. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00103 · Cited by 102
“Up-regulation of p53 leads to induced expression of different mitochondria associated proteins (e.g., Bax and Puma, linked to mitochondrial depolarization) and activation of apoptosis (Chipuk et al., 2004; La Spada and Morrison, 2005).”
Xiong, F., Ling, X., Chen, X., Chen, J., Tan, J., Cao, W., Ge, L., Ma, M., & Wu, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00824 · Cited by 103
Shankar, S., Chen, Q., Siddiqui, I. A., Sarva, K., & Srivastava, R. K. (2007) · Journal of Molecular Signaling · doi:10.1186/1750-2187-2-7 · Cited by 110
“Although most data suggest that p53 regulates its activities through transcription activation, there is growing evidence that p53 exerts pro-apoptotic activity in a transcription-independent manner [61].”
BackgroundAlterations of theTP53Gene in Gastric and Esophageal Carcinogenesis
Bellini, M. F., Cadamuro, A. C. T., Succi, M., Proença, M. A., & Silva, A. E. (2012) · BioMed Research International · doi:10.1155/2012/891961 · Cited by 108
“Under cellular stress, p53 accumulates in the cytosol or mitochondria and leads to the direct activation of proapoptotic Bcl-2 family members, such as Bax and/or Bak [57, 58], so it selectively activates p53-mediated apoptosis.”
Backgroundp73 regulates DRAM-independent autophagy that does not contribute to programmed cell death
Crighton, D., O’Prey, J., Bell, H. S., & Ryan, K. M. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402108 · Cited by 115
How do reactive oxygen species and calcium trigger mitochondrial membrane permeabilisation?
Tajeddine, N. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.02.013 · Cited by 108
Redox Imbalance in the Development of Colorectal Cancer
Liu, H., Liu, X., Zhang, C., Zhu, H., Xu, Q., Bu, Y., & Lei, Y. (2017) · Journal of Cancer · doi:10.7150/jca.18735 · Cited by 114
“Oxidization suppressed p53 transcriptional activity which subsequently inactivated targeted genes like Bax and bcl-2 expression and resulted in apoptosis inhibition that may induce CRC [105-107].”
BackgroundVitiligo: Pathogenetic Hypotheses and Targets for Current Therapies
Guerra, L., Dellambra, E., Brescia, S., & Raskovic, D. (2010) · Current Drug Metabolism · doi:10.2174/138920010791526105 · Cited by 103
Girardi, C., Pittà, C. D., Casara, S., Sales, G., Lanfranchi, G., Celotti, L., & Mognato, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031293 · Cited by 110
“To investigate on the differences of DDR pathway between 1 g and MMG conditions, we focused on p53-pathway, which is pivotal in eliciting a complex DDR in response to genotoxic and non-genotoxic stresses [74–77].”
Hu, H., Jiang, C., Schuster, T. F., Li, G.-X., Daniel, P. T., & Lü, J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0063 · Cited by 104
“Because Bax is a downstream transcriptional target of p53 (31), these results”
BackgroundChipuk, J. E., & Green, D. R. (2009) · Cell Cycle · doi:10.4161/cc.8.17.9412 · Cited by 116
Self-citationLeu, J. I.-J., & George, D. L. (2007) · Genes & Development · doi:10.1101/gad.1567107 · Cited by 101
“…et al. 1994; Haupt et al. 1995; Chen et al. 1996; Ljungman et al. 1999; Chipuk et al. 2003; Speidel et al. 2006) with a direct apoptotic role at mitochondria (Marchenko et al. 2000; Dumont et al. 2003; Mihara et al. 2003; Chipuk et al. 2004; Leu et al. 2004; Arima et al. 2005; Strom et al. 2006).”
BackgroundCastrogiovanni, C., Waterschoot, B., Backer, O. D., & Dumont, P. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.143 · Cited by 105
Cao, F., Wu, P., Huang, L., Li, H., Qian, L., Pang, S., & Qiu, L. (2018) · Aquatic Toxicology · doi:10.1016/j.aquatox.2018.02.023 · Cited by 104
Wan, J., Liu, T., Mei, L., Li, J., Gong, K., Yu, C., & Li, W. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.334 · Cited by 105
“Previous reports indicate that the absence of Bax blocks apoptosis and increases drug resistance in many cancers (McCurrach et al, 1997; Chipuk et al, 2004; Letai, 2008).”
BackgroundMSL2 Promotes Mdm2-independent Cytoplasmic Localization of p53
Kruse, J.-P., & Gu, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805658200 · Cited by 100
Overexpression of Sp1 transcription factor induces apoptosis
Deniaud, E., Baguet, J., Mathieu, A., Pagès, G., Marvel, J., & Leverrier, Y. (2006) · Oncogene · doi:10.1038/sj.onc.1209696 · Cited by 100
“(Demeret et al., 2003; Chipuk et al., 2004).”
BackgroundYang, L., Wu, D., Luo, K.-W., Wu, S., & Wu, P. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.11.015 · Cited by 104
“Bax activation and translocation can be activated directly by several regulators such as Bid [22], Bim [41] and p53 [42].”
BackgroundThe role of Bcl-2 family proteins in chronic lymphocytic leukaemia
Buggins, A. G. S., & Pepper, C. J. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.03.011 · Cited by 112
Gogada, R., Prabhu, V. V., Amadori, M., Scott, R., Hashmi, S., & Chandra, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.202440 · Cited by 107
p53-mediated neuronal cell death in ischemic brain injury
Hong, L.-Z., Zhao, X.-Y., & Zhang, H.-L. (2010) · Neuroscience Bulletin · doi:10.1007/s12264-010-1111-0 · Cited by 106
“[11] Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, et al.”
BackgroundModulating apoptosis as a target for effective therapy
Fleischer, A., Ghadiri, A., Dessauge, F., Duhamel, M., Rebollo, M. P., Alvarez-Franco, F., & Rebollo, A. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.07.013 · Cited by 108
Genetic determinants at the interface of cancer and neurodegenerative disease
Morris, L. G. T., Veeriah, S., & Chan, T. A. (2010) · Oncogene · doi:10.1038/onc.2010.127 · Cited by 98
“…al., 1998; Canman et al., 1998; Lavin and Kozlov, 2007). p53 then either inhibits the cell cycle by inducing expression of p21 and 14–3–3a, or induces Puma, Noxa, and Bax, causing apoptosis (Xiong et al., 1993; el-Deiry et al., 1993; Yu et al., 2003; Chipuk et al., 2004; Meulmeester et al., 2005).”
Kerley-Hamilton, J. S., Pike, A. M., Li, N., DiRenzo, J., & Spinella, M. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208755 · Cited by 114
“Further, our study does not address several transcription-independent mechanisms of p53-mediated apoptosis including the recent demonstration of a direct p53– Bax interaction (Chipuk et al., 2004).”
BackgroundQanungo, S., Wang, M., & Nieminen, A.-L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406749200 · Cited by 99
Focal Adhesion Kinase Versus p53: Apoptosis or Survival?
Cance, W. G., & Golubovskaya, V. (2008) · Science Signaling · doi:10.1126/stke.120pe22 · Cited by 104
Regulation of Bcl-2 proteins and of the permeability of the outer mitochondrial membrane
Lucken-Ardjomande, S., & Martinou, J.-C. (2005) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2005.05.002 · Cited by 98
Yang, C., Kaushal, V., Haun, R. S., Seth, R., Shah, S. V., & Kaushal, G. P. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402287 · Cited by 101
HDAC Inhibitor, Valproic Acid, Induces p53-Dependent Radiosensitization of Colon Cancer Cells
Chen, X., Wong, P. W., Radany, E. H., & Wong, J. Y. C. (2009) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2009.0629 · Cited by 105
“46,49,50 The observed VPA enhancement of radiation-induced tumor growth suppression in vivo further supports the fact VPA, and possibly other HDAC inhibitors, may be potentially useful in improving tumor response to radiotherapy in the clinical setting, especially for cancers with the wild-type p53…”
Tang, C., Lu, Y.-H., Xie, J., Wang, F., Zou, J.-N., Yang, J.-S., Xing, Y., & Xi, T. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328327d476 · Cited by 97
Cell death via mitochondrial apoptotic pathway due to activation of Bax by lysosomal photodamage
Liu, L., Zhang, Z., & Xing, D. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.042 · Cited by 109
Kang, K. P., Park, S. K., Kim, D. H., Sung, M. J., Jung, Y. J., Lee, A. S., Lee, J. E., Ramkumar, K. M., Lee, S., Park, M. H., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq528 · Cited by 98
“A study has demonstrated that p53 directly activates the pro-apoptotic Bax and induces transcriptionindependent apoptosis [31].”
BackgroundMitochondrial death functions of p53
Marchenko, N. D., & Moll, U. M. (2014) · Molecular & Cellular Oncology · doi:10.1080/23723548.2014.955995 · Cited by 115
“p53 can then bind and activate monomeric Bax in the cytoplasm via transient formation of a ‘hit-and-run’ complex, causing Bax homooligomerization and translocation to the outer membrane.(5,26) This mechanism appears to be cell-context dependent because the p53 transcription-independent direct mitochondrial apoptotic p…”
BackgroundPin1-Induced Proline Isomerization in Cytosolic p53 Mediates BAX Activation and Apoptosis
Follis, A. V., Llambi, F., Merritt, P., Chipuk, J. E., Green, D. R., & Kriwacki, R. W. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.029 · Cited by 96
“We used cell lines that constitutively expressed Tamoxifeninducible p53 (Chipuk et al., 2004) (p53-ERTam wild-type; S46A; P47S), with endogenous or overexpressed Pin1 (Figures 4A; Figures S4A–S4D), to test the cellular relevance of the Pin1-facilitated, p53-NTD-dependent BAX activation mecha- nism…”
InfluentialSelf-citationBender, A., Opel, D., Naumann, I., Kappler, R., Friedman, L. S., von Schweinitz, D., Debatin, K., & Fulda, S. (2010) · Oncogene · doi:10.1038/onc.2010.429 · Cited by 100
Selective and Potent Proteomimetic Inhibitors of Intracellular Protein–Protein Interactions
Barnard, A., Long, K., Martin, H. L., Miles, J. A., Edwards, T. A., Tomlinson, D. C., Macdonald, A., & Wilson, A. J. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201410810 · Cited by 108
Ross, K. C., Andrews, A. J., Marion, C. D., Yen, T. J., & Bhattacharjee, V. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0798 · Cited by 96
“Gemcitabine causes DNA double strand breaks (DSB) as a result of replication fork collapse in the S-phase of the cell cycle in p53-mutated cells or induces apoptosis through PUMA (39) and Bax (40) mediated cell death programs in G1 in p53 WT cells.”
BackgroundMai, W. X., Gosa, L., Daniels, V. W., Ta, L., Tsang, J. E., Higgins, B., Gilmore, W. B., Bayley, N. A., Harati, M. D., Lee, J. T., et al. (2017) · Nature Medicine · doi:10.1038/nm.4418 · Cited by 96
Cardiac Glycosides Inhibit p53 Synthesis by a Mechanism Relieved by Src or MAPK Inhibition
Wang, Z., Zheng, M., Li, Z. F., Li, R., Jia, L., Xiong, X., Southall, N. T., Wang, S., Xia, M., Austin, C. P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0891 · Cited by 105
“apoptosis in a transcription-independent manner (2, 3).”
Negrette-Guzmán, M., Huerta‐Yépez, S., Tapia, E., & Pedraza‐Chaverrí, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.182 · Cited by 99
Chrisanthar, R., Knappskog, S., Løkkevik, E., Anker, G. B., Østenstad, B., Lundgren, S., Berge, E. O., Risberg, T., Mjaaland, I., Mæhle, L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003062 · Cited by 103
“Yet, recent evidence has revealed p53 to induce apoptosis through non-transcriptional mechanisms by direct protein interactions with members of the Bcl-2/Bax system and mitochondrial release of cytochrom c [57,69].”
BackgroundNair, V. D., McNaught, K. S. P., González-Maeso, J., Sealfon, S. C., & Olanow, C. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603950200 · Cited by 96
New tricks of an old molecule: lifespan regulation by p53
Bauer, J. H., & Helfand, S. L. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00228.x · Cited by 105
Munagala, R., Aqil, F., Jeyabalan, J., & Gupta, R. C. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.037 · Cited by 100
p53-based cancer therapies: is defective p53 the Achilles heel of the tumor?
Levesque, A. A., & Eastman, A. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl214 · Cited by 95
Huang, Y., Liu, N., Liu, J., Liu, Y., Zhang, C., Long, S., Luo, G., Zhang, L., & Zhang, Y. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1688951 · Cited by 94
“Thirdly, previous studies have shown that WT p53 can directly activate BAX by their interaction and changing BAX conformation [54].”
BackgroundLi, X., Yao, Z., Yang, D., Jiang, X., Sun, J., Tian, L., Hu, J., Wu, B., & Bai, W. (2019) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.121706 · Cited by 95
Gosslau, A., Jao, D. L., Huang, M., Ho, C., Evans, D., Rawson, N. E., & Chen, K. Y. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000165 · Cited by 94
“Induction of p53 is thought to be the major cause for apoptosis by triggering Bax activation, which favors the permeability of mitochondrial membranes [28].”
BackgroundInfluentialGiovannini, C., Gramantieri, L., Chieco, P., Minguzzi, M., Lago, F., Pianetti, S., Ramazzotti, E., Marcu, K. B., & Bolondi, L. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.032 · Cited by 94
“Next we further examined the contributions of p53 for doxorubicin-induced apoptosis of HepG2 and SNU398 cells by analyzing the phosphorylation status of ser20-p53 in addition to assessing the expression levels of several direct p53 target genes (NOXA, Bax and BNIP3) [25–27] in conjunction with annexin V-FITC fluoresce…”
BackgroundOleuropein Induces Apoptosis Via the p53 Pathway in Breast Cancer Cells
Hassan, Z. K., Elamin, M. H., Omer, S. A., Daghestani, M. H., Al-Olayan, E. S., Elobeid, M., & Virk, P. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.11.6739 · Cited by 95
“Similarly in previous study, the up-regulated P53 directly promotes Bax expression that destroys the integrity of the mitochondria to induce apoptosis (Chipuk et al., 2004).”
BackgroundRoh, J.-L., Kang, S. K., Minn, I., Califano, J. A., Sidransky, D., & Koch, W. M. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2010.10.011 · Cited by 93
Polymorphic variants in the p53 pathway
Murphy, M. E. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401907 · Cited by 99
Metadata
- Authors
- Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R.
- Affiliations
- La Jolla Institute for Immunology (US)
- Division of Cellular Immunology, La Jolla Institute for Allergy and Immunology, 10355 Science Center Drive, San Diego, CA 92121, USA.
- Corresponding author
- Green, Douglas R.
- Venue
- Science
- Published
- 2004-02-13
- Volume
- 303
- Issue
- 5660
- Pages
- 1010-1014
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1616121322
- Semantic Scholar
- 8ac054acf921abc9f97df5fd7ea018d60ed0c524
- Cited by
- 2,108
- References
- 29
- Citations by year
- 2026: 38 · 2025: 59 · 2024: 60 · 2023: 68 · 2022: 78 · 2021: 88 · 2020: 81 · 2019: 84 · 2018: 88 · 2017: 93 · 2016: 100 · 2015: 91 · 2014: 103 · 2013: 113 · 2012: 103
- FWCI
- 40.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM-52735)
- National Institute of Allergy and Infectious Diseases (R01AI040646, R01AI047891)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- p53, Bax, apoptosis, mitochondrial membrane permeabilization, Bcl-2 family proteins, BH3-only proteins, Bcl-xL, Bid, tumor suppressor
- MeSH terms
- Animals, Carrier Proteins, Cell Line, Transformed, Cell Nucleus, Cells, Cultured, Cytosol, Gene Expression Regulation, HeLa Cells, Humans, Intracellular Membranes, Liposomes, Mitochondria, Mutation, Permeability, Protein Conformation, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Ultraviolet Rays, Wheat Germ Agglutinins, Genes, p53, Tumor Suppressor Protein p53, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Cytochromes c, bcl-X Protein, BH3 Interacting Domain Death Agonist Protein, bcl-2-Associated X Protein, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.